Key facts
- This page summarizes Tyler Lipschultz's Form 4 filing for SeaSpine Holdings Corp.
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 02 Mar 2022, 19:38.
Tyler Lipschultz - 28 Feb 2022 Form 4 Insider Report for SeaSpine Holdings Corp
- Reporting relationship
- SVP, Orthobiologics and BD
- Issuer ticker
- N/A
- Reported as of
- 28 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Mar 2022, 19:38:42 UTC
- Prior SEC filing
- 01 Feb 2022
- Next SEC filing
- 30 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/Paul Benny, Attorney-in-Fact for Tyler Lipschultz
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Tyler Lipschultz filed Form 4 for SeaSpine Holdings Corp on 02 Mar 2022.
Change
- Previous filing in this sequence was filed on 01 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SPNE
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +33,977
- Change %
- Price
- $0.000000
- Shares after
- 33,977
- Date
- 28 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 33,977
- Exercise price
- Footnotes
- F1, F2
SPNE
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +21,236
- Change %
- Price
- $0.000000
- Shares after
- 21,236
- Date
- 28 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,236
- Exercise price
- $15.00
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
Footnote F2
The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
Footnote F3
The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.